About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 803487, 10 pages
http://dx.doi.org/10.1155/2013/803487
Review Article

Genetic Epidemiology, Hematological and Clinical Features of Hemoglobinopathies in Iran

1Medical Biology Research Center, Kermanshah University of Medical Sciences, Daneshgah Avenue, P.O. Box 67148-69914, Kermanshah, Iran
2Department of Biochemistry, Medical School, Kermanshah University of Medical Sciences, Daneshgah Avenue, P.O. Box 67148-69914, Kermanshah, Iran

Received 6 April 2013; Accepted 3 June 2013

Academic Editor: Bipin Savani

Copyright © 2013 Zohreh Rahimi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Weatherall, “Current trends in the diagnosis and management of haemoglobinopathies,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 67, no. 1, pp. 1–2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Old, “Screening and genetic diagnosis of haemoglobinopathies,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 67, no. 1, pp. 71–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Weatherall, “The inherited diseases of hemoglobin are an emerging global health burden,” Blood, vol. 115, no. 22, pp. 4331–4336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. López, C. Saravia, A. Gomez, J. Hoebeke, and M. A. Patarroyo, “Mechanisms of genetically-based resistance to malaria,” Gene, vol. 467, no. 1-2, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. L. Shear, L. Grinberg, J. Gilman et al., “Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism,” Blood, vol. 92, no. 7, pp. 2520–2526, 1998. View at Scopus
  6. T. N. Williams, “Human red blood cell polymorphisms and malaria,” Current Opinion in Microbiology, vol. 9, no. 4, pp. 388–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Weatherall, J. Clegg, and D. Kwiatkowski, “The role of genomics in studying genetic susceptibility to infectious disease,” Genome Research, vol. 7, no. 10, pp. 967–973, 1997. View at Scopus
  8. A. Raeisi, F. Nikpoor, M. R. Kahkha, and L. Faraji, “The trend of malaria in Islamic Republic Iran from 2002 to 2007,” Hakim Research Journal, vol. 12, pp. 35–41, 2009 (Persian).
  9. B. Farzinnia, A. Saghafipour, and M. R. Abai, “Malaria situation and anopheline mosquitoes in Qom Province, Central Iran,” Iranian Journal of Arthropod-Borne Diseases, vol. 4, no. 2, pp. 61–67, 2010. View at Scopus
  10. A. A. Hanafi-Bojd, H. Vatandoost, E. Philip et al., “Malaria situation analysis and stratification in Bandar Abbas County, Southern Iran, 2004–2008,” Iranian Journal of Arthropod-Borne Diseases, vol. 4, no. 1, pp. 31–41, 2010. View at Scopus
  11. N. Ghotbi and T. Tsukatani, “Evaluation of the national health policy of thalassaemia screening the Islamic Republic of Iran,” Eastern Mediterranean Health Journal, vol. 11, no. 3, pp. 308–318, 2005. View at Scopus
  12. P. Nikuei, V. Hadavi, M. Rajaei, M. Saberi, F. Hajizade, and H. Najmabadi, “Prenatal diagnosis for β-thalassemia major in the Iranian Province of Hormozgan,” Hemoglobin, vol. 32, no. 6, pp. 539–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ebrahimzadeh, B. Fouladi, and A. Fazaeli, “High rate of detection of mixed infections of Plasmodium vivax and Plasmodium falciparum in South-East of Iran, using nested PCR,” Parasitology International, vol. 56, no. 1, pp. 61–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Soleimanifard, M. Akbari, M. Sabetghadam, and S. Saberi, “Malaria situation in Isfahan in the last five years,” Journal of Isfahan Medical School, vol. 29, pp. 273–280, 2011 (Persian). View at Scopus
  15. B. S. Strauss, “Genetic counseling for thalassemia in the Islamic Republic of Iran,” Perspectives in Biology and Medicine, vol. 52, no. 3, pp. 364–376, 2009. View at Scopus
  16. D. J. Weatherall, J. B. Clegg, D. R. Higgs, and W. G. Wood, “The hemoglobinopathies,” in The Metabolic and Molecular Basis of Inherited Disease, C. R. Sriver, A. Beadet, W. S. Sly, and D. Valle, Eds., vol. 3, pp. 3417–3484, McGraw-Hill, New York, NY, USA, 1995.
  17. Z. Rahimi and A. Parsian, “Sickle cell disease and venous thromboembolism,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 3, Article ID e2011024, 2011.
  18. M. Haghshenass, F. Ismail-Beigi, J. B. Clegg, and D. J. Weatherall, “Mild sickle cell anaemia in Iran associated with high levels of fetal haemoglobin,” Journal of Medical Genetics, vol. 14, no. 3, pp. 168–171, 1977. View at Scopus
  19. F. Habibzadeh, M. Yadollahie, M. Ayatollahie, and M. Haghshenass, “The prevalence of sickle cell syndrome in South of Iran,” Iranian Journal of Medical Sciences, vol. 24, pp. 32–34, 1999.
  20. S. Rahgozar, A. A. Poorfathollah, A. R. Moafi, and J. M. Old, “βSgene in Central Iran is in linkage disequilibrium with the Indian-Arab haplotype,” The American Journal of Hematology, vol. 65, no. 3, pp. 192–195, 2000.
  21. Z. Rahimi, A. Muniz, and H. Mozafari, “Abnormal hemoglobins among Kurdish population of Western Iran: Hematological and molecular features,” Molecular Biology Reports, vol. 37, no. 1, pp. 51–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Rahimi, R. Akramipour, R. L. Nagel, A. S. Ahmadi, A. Merat, and F. Bahrehmand, “The β-globin gene haplotypes associated with Hb D-Los Angeles [β121(GH4)Glu→Gln] in Western Iran,” Hemoglobin, vol. 30, no. 1, pp. 39–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Rahbar, G. Nowzari, and M. Poosti, “A double heterozygous hemoglobin: hemoglobin O(Indonesia) and hemoglobin D(Punjab) in an individual,” The American Journal of Clinical Pathology, vol. 64, no. 3, pp. 416–420, 1975. View at Scopus
  24. H. Galehdari, B. Salehi, S. Azmoun, B. Keikhaei, K. M. Zandian, and M. Pedram, “Comprehensive spectrum of the β-thalassemia mutations in Khuzestan, Southwest Iran,” Hemoglobin, vol. 34, no. 5, pp. 461–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Rahimi, R. Akramipour, S. Korani, and R. L. Nagel, “Hb D-punjab [β 121 (GH4) Glu→Gln]/β0-thalassemia [IVSII.1(G→A)] in two cases from an Iranian family: first report,” The American Journal of Hematology, vol. 81, no. 4, pp. 302–303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. T. Basmanj, M. Karimipoor, A. Amirian et al., “Co-inheritance of hemoglobin D and β-thalassemia traits in three Iranian families: clinical relevance,” Archives of Iranian Medicine, vol. 14, no. 1, pp. 61–63, 2011. View at Scopus
  27. P. A. Lorkin, D. Charlesworth, H. Lehmann, S. Rahbar, S. Tuchinda, and L. I. Eng, “Two haemoglobins Q, α-74 (EF3) and α-75 (EF4) aspartic acid→histidine,” The British Journal of Haematology, vol. 19, no. 1, pp. 117–125, 1970. View at Scopus
  28. M. Aksoy, A. Gurgey, C. Altay et al., “Some notes about Hb Q-India and Hb Q-Iran,” Hemoglobin, vol. 10, no. 2, pp. 215–219, 1986. View at Scopus
  29. Z. Rahimi, M. Rezaei, R. L. Nagel, and A. Muniz, “Molecular and hematologic analysis of hemoglobin Q-Iran and hemoglobin Setif in Iranian families,” Archives of Iranian Medicine, vol. 11, no. 4, pp. 382–386, 2008. View at Scopus
  30. Z. Rahimi, A. Merat, N. Gerard, R. Krishnamoorthy, and R. L. Nagel, “Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in Southern Iran,” Human Biology, vol. 78, no. 6, pp. 719–731, 2006. View at Scopus
  31. Z. Rahimi, M. Karimi, M. Haghshenass, and A. Merat, “β-globin gene cluster haplotypes in sickle cell patients from Southwest Iran,” The American Journal of Hematology, vol. 74, no. 3, pp. 156–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Rahimi, A. Vaisi-Raygani, A. Merat, M. Haghshenass, and M. Rezaei, “Level of hemoglobin F and Gγ gene expression in sickle cell disease and their association with haplotype and XmnI polymorphic site in South of Iran,” Iranian Journal of Medical Sciences, vol. 32, no. 4, pp. 234–239, 2007. View at Scopus
  33. M. Yavarian, M. Karimi, F. Paran, C. Neven, C. L. Harteveld, and P. C. Giordano, “Multi centric origin of Hb D-Punjab [β121(GH4)Glu→Gln, GAA→CAA],” Hemoglobin, vol. 33, no. 6, pp. 399–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Rahimi, R. Akramipour, A. Vaisi-Raygani, R. L. Nagel, and A. Muniz, “An Iranian child with HbQ-Iran [α75 (EF4) Asp→His]/α3.7kb/IVSII.1 G→A: first report,” Journal of Pediatric Hematology/Oncology, vol. 29, no. 9, pp. 649–651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. N. E. Cousens, C. L. Gaff, S. A. Metcalfe, and M. B. Delatycki, “Carrier screening for β-thalassaemia: a review of international practice,” European Journal of Human Genetics, vol. 18, no. 10, pp. 1077–1083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. E. A. Rachmilewitz and P. J. Giardina, “How I treat thalassemia,” Blood, vol. 118, no. 13, pp. 3479–3488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Rahimi, A. V. Raygani, A. Merat et al., “Thalassemic mutations in southern Iran,” Iranian Journal of Medical Sciences, vol. 31, no. 2, pp. 70–73, 2006. View at Scopus
  38. A. Valaei, F. Bayat, A. Kordafshari, S. Zeinali, and M. Karimipoor, “A novel polymorphism causes a different restriction pattern by RsaI in the β-globin gene cluster: application in prenatal diagnosis,” Hemoglobin, vol. 33, no. 6, pp. 417–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Karimi, N. Jamalian, H. Yarmohammadi, A. Askarnejad, A. Afrasiabi, and A. Hashemi, “Premarital screening for β-thalassaemia in Southern Iran: options for improving the programme,” Journal of Medical Screening, vol. 14, no. 2, pp. 62–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Merat, M. Haghshenas, Z. M. Pour et al., “β-thalassemia in Southwestern Iran,” Hemoglobin, vol. 17, no. 5, pp. 427–437, 1993. View at Scopus
  41. M. Karimi, H. Yarmohammadi, S. Farjadian et al., “β-thalassemia intermedia from Southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele,” Hemoglobin, vol. 26, no. 2, pp. 147–154, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Yavarian, C. L. Harteveld, D. Batelaan, L. F. Bernini, and P. C. Giordano, “Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan,” Hemoglobin, vol. 25, no. 1, pp. 35–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Najmabadi, R. Karimi-Nejad, S. Sahebjam et al., “The β-thalassemia mutation spectrum in the iranian population,” Hemoglobin, vol. 25, no. 3, pp. 285–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Derakhshandeh-Peykar, H. Akhavan-Niaki, A. Tamaddoni et al., “Distribution of β-thalassemia mutations in the Northern Provinces of Iran,” Hemoglobin, vol. 31, no. 3, pp. 351–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Akhavan-Niaki, P. Derakhshandeh-Peykar, A. Banihashemi et al., “A comprehensive molecular characterization of β thalassemia in a highly heterogeneous population,” Blood Cells, Molecules, and Diseases, vol. 47, no. 1, pp. 29–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. H. Feizi, A. A. H. Feizi, N. Pouladi, M. Haghi, and P. Azarfam, “Molecular spectrum of β-thalassemia mutations in Northwestern Iran,” Hemoglobin, vol. 32, no. 3, pp. 255–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Rahimi, A. Muniz, and A. Parsian, “Detection of responsible mutations for β thalassemia in the Kermanshah Province of Iran using PCR-based techniques,” Molecular Biology Reports, vol. 37, no. 1, pp. 149–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Haghi, S. Khorshidi, M. A. H. Feizi, N. Pouladi, and A. A. H. Feizi, “β-thalassemia mutations in the iranian kurdish population of kurdistan and west azerbaijan provinces,” Hemoglobin, vol. 33, no. 2, pp. 109–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Kiani, Y. Mortazavi, S. Zeinali, and Y. Shirkhani, “The molecular analysis of β-thalassemia mutations in Lorestan Province, Iran,” Hemoglobin, vol. 31, no. 3, pp. 343–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Salehi, C. A. Fisher, P. A. Bignell, G. Eslami, and J. M. Old, “Identification of three novel mutations [-41 (A>C), codon 24 (G), and IVS-I-109 (-T)], in a study of β-thalassemia alleles in the Isfahan Region of Iran,” Hemoglobin, vol. 34, no. 1, pp. 115–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Miri-Moghaddam, A. Zadeh-Vakili, Z. Rouhani, M. Naderi, P. Eshghi, and A. K. Feizabad, “Molecular basis and prenatal diagnosis of β-thalassemia among Balouch population in Iran,” Prenatal Diagnosis, vol. 31, no. 8, pp. 788–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Saleh-Gohari and M. R. Bazrafshani, “Distribution of β-globin gene mutations in thalassemia minor population of kerman province, Iran,” Iranian Journal of Public Health, vol. 39, no. 2, pp. 69–76, 2010. View at Scopus
  53. R. Galanello and R. Origa, “β-thalassemia,” Orphanet Journal of Rare Diseases, vol. 5, no. 1, article 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. L. Thein, “Genetic modifiers of β-thalassemia,” Haematologica, vol. 90, no. 5, pp. 649–660, 2005. View at Scopus
  55. D. J. Weatherall, “Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic diseases,” The British Medical Journal, vol. 321, no. 7269, pp. 1117–1120, 2000. View at Scopus
  56. Z. Rahimi, A. Muniz, R. Akramipour et al., “Haplotype analysis of β thalassemia patients in Western Iran,” Blood Cells, Molecules, and Diseases, vol. 42, no. 2, pp. 140–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Yavarian, M. Karimi, E. Bakker, C. L. Harteveld, and P. C. Giordano, “Response to hydroxyurea treatment in Iranian transfusion-dependent β-thalassemia patients,” Haematologica, vol. 89, no. 10, pp. 1172–1178, 2004. View at Scopus
  58. H. Nemati, Z. Rahimi, and G. Bahrami, “The Xmn1 polymorphic site 5′ to the Gγ gene and its correlation to the Gγ : Aγ ratio, age at first blood transfusion and clinical features in β-thalassemia patients from Western Iran,” Molecular Biology Reports, vol. 37, no. 1, pp. 159–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. T. Akbari, P. Izadi, M. Izadyar, K. Kyriacou, and M. Kleanthous, “Molecular basis of thalassemia intermedia in Iran,” Hemoglobin, vol. 32, no. 5, pp. 462–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Hamid, F. Mahjoubi, M. T. Akbari, A. Arab, S. Zeinali, and M. Karimipoor, “Molecular analysis of γ-globin promoters, HS-111 and 3′HS1, in β-thalassemia intermedia patients associated with high levels of Hb F,” Hemoglobin, vol. 33, no. 6, pp. 428–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. D. R. Higgs and D. J. Weatherall, “The α thalassaemias,” Cellular and Molecular Life Sciences, vol. 66, no. 7, pp. 1154–1162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. C. L. Harteveld, M. Yavarian, A. Zorai, E. D. Quakkelaar, P. van Delft, and P. C. Giordano, “Molecular spectrum of α-thalassemia in the Iranian population of hormozgan: three novel point mutation defects,” The American Journal of Hematology, vol. 74, no. 2, pp. 99–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Zandian, J. Nateghi, B. Keikhaie et al., “α-thalassemia mutations in Khuzestan Province, Southwest Iran,” Hemoglobin, vol. 32, no. 6, pp. 546–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Hossein, R. Mohsen, M. Mohsen, and M. Taheri, “α-thalassemia mutations in two provinces of Southern Iran: Fars & Kohkeloye and Bouyer Ahmad,” Hemoglobin, vol. 36, no. 2, pp. 139–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Tamaddoni, V. Hadavi, N. H. Nejad et al., “α-thalassemia mutation analyses in mazandaran province, north iran,” Hemoglobin, vol. 33, no. 2, pp. 115–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Hadavi, M. Jafroodi, N. Hafezi-Nejad et al., “α-thalassemia mutations in Gilan Province, North Iran,” Hemoglobin, vol. 33, no. 3-4, pp. 235–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Saleh-Gohari and A. Khosravi-Mashizi, “Spectrum of α-globin gene mutations in the Kerman province of Iran,” Hemoglobin, vol. 34, no. 5, pp. 451–460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Hadavi, A. H. Taromchi, M. Malekpour et al., “Elucidating the spectrum of α-thalassemia mutations in Iran,” Haematologica, vol. 92, no. 7, pp. 992–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S. T. Singer, “Variable clinical phenotypes of α-thalassemia syndromes,” TheScientificWorldJournal, vol. 9, pp. 615–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Zeinali, M. Fallah, and H. Bagherian, “Heterogeneity of hemoglobin H disease in childhood,” The New England Journal of Medicine, vol. 364, no. 21, pp. 2070–2071, 2011. View at Scopus
  71. A. R. Cohen, R. Galanello, D. J. Pennell, M. J. Cunningham, and E. Vichinsky, “Thalassemia,” Hematology/American Society of Hematology, Education Program, pp. 14–34, 2004. View at Scopus
  72. M. Yavarian, M. Karimi, A. Zorai, C. L. Harteveld, and P. C. Giordano, “Molecular basis of Hb H disease in southwest Iran,” Hemoglobin, vol. 29, no. 1, pp. 43–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Ebrahimkhani, A. Azarkeivan, N. Bayat et al., “Genotype-phenotype correlation in Iranian patients with Hb H disease,” Hemoglobin, vol. 35, no. 1, pp. 40–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Samavat and B. Modell, “Iranian national thalassaemia screening programme,” The British Medical Journal, vol. 329, no. 7475, pp. 1134–1137, 2004. View at Scopus
  75. M. Ghanei, P. Adibi, M. Movahedi et al., “Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan,” Public Health, vol. 111, no. 3, pp. 153–156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Christianson, A. Streetly, and A. Darr, “Lessons from thalassaemia screening in Iran,” The British Medical Journal, vol. 329, no. 7475, pp. 1115–1117, 2004. View at Scopus